These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 11818155)
1. Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences. Ghosh MK; Dériaud E; Saron MF; Lo-Man R; Henry T; Jiao X; Roy P; Leclerc C Vaccine; 2002 Jan; 20(9-10):1369-77. PubMed ID: 11818155 [TBL] [Abstract][Full Text] [Related]
2. Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope. Shams H; Poblete F; Rüssmann H; Galán JE; Donis RO Vaccine; 2001 Nov; 20(3-4):577-85. PubMed ID: 11672924 [TBL] [Abstract][Full Text] [Related]
3. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes. Slifka MK; Shen H; Matloubian M; Jensen ER; Miller JF; Ahmed R J Virol; 1996 May; 70(5):2902-10. PubMed ID: 8627765 [TBL] [Abstract][Full Text] [Related]
4. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Saron MF; Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3314-9. PubMed ID: 9096390 [TBL] [Abstract][Full Text] [Related]
5. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection. Klavinskis LS; Whitton JL; Oldstone MB J Virol; 1989 Oct; 63(10):4311-6. PubMed ID: 2476571 [TBL] [Abstract][Full Text] [Related]
6. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity. Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055 [TBL] [Abstract][Full Text] [Related]
7. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501 [TBL] [Abstract][Full Text] [Related]
8. In vivo induction of CTL responses by recombinant adenylate cyclase of Bordetella pertussis carrying viral CD8+ T cell epitopes. Fayolle C; Sebo P; Ladant D; Ullmann A; Leclerc C J Immunol; 1996 Jun; 156(12):4697-706. PubMed ID: 8648115 [TBL] [Abstract][Full Text] [Related]
9. Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Klavinskis LS; Whitton JL; Joly E; Oldstone MB Virology; 1990 Oct; 178(2):393-400. PubMed ID: 1699348 [TBL] [Abstract][Full Text] [Related]
10. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen. Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673 [TBL] [Abstract][Full Text] [Related]
11. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells. Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199 [TBL] [Abstract][Full Text] [Related]